In mouse models of cancer cachexia, the antibody-mediated inhibition of GDF15-GFRAL has been shown in distinct studies to reverse the loss of adipose and muscle mass of tumor-bearing subjects [148], to improve muscle function and physical performance [149], and to reduce chemotherapy-induced weight loss [150]. Here, GDF15 is linked to neoplasm.